A 68-year-old woman was admitted to determine the pathogenesis of weight loss and polyuria. Physical findings on admission showed BMI of 20.9, blood pressure of 147/69 mmHg, and that she had ciliac, axillar and pubic hair loss. Laboratory findings showed that plasma adrenocorticotropic hormone (ACTH) was 4.6 pg/mL with serum cortisol of 1.2 μg/dL. Serum luteinizing hormone (LH) and follicle-stimulating hormone (FSH) were markedly reduced. Serum growth hormone (GH) and insulin growth factor (IGF)-1 were 0.054 ng/mL and 25 ng/mL, respectively. Serum prolactin was as high as 85.6 ng/mL. The levels of all the pituitary hormones were elevated in response to a mixture of exogenous corticotrophin-releasing hormone (CRH), luteinizing hormone-releasing hormone (LH-RH), thyrotropin-releasing hormone (TRH), and growth hormonereleasing hormone (GRH). However, there was no response of ACTH and GH release to insulin-induced hypoglycemia and no response of LH and FSH release to clomiphene. Urine volume was more than 4,000 mL, with low urine osmolality of 134 mmol/kg. Plasma arginine vasopressin (AVP) was 0.8 pg/mL. There was no increase in urine osmolality and plasma AVP in response to 5% hypertonic saline load. Magnetic resonance imaging revealed Rathke's cleft cyst at the pituitary stalk level, but there was no abnormal finding in the hypothalamus. These findings indicate central diabetes insipidus and hypothalamic type of hypopituitarism, resulting from the atypical location of Rathke's cleft cyst.
Introduction
Rathke's cleft cyst (RCC) is a well-known remnant of embryonic Rathke's pouch. In general, Rathke's pouch regresses on formation of adenohypophysis and neurohypophysis. Interestingly however, RCC has been clarified in 13-22% of normal autopsies (1) (2) (3) (4) (5) , and it has became more common as an incidental cyst as a result of the widespread use of magnetic resonance imaging (MRI) (6) . RCC can become enlarged because of either inflammation or hemorrhagic change (7, 8) , but pituitary dysfunction does not always relate to the size of RCC. Other factors, for example, inflammatory change of the pituitary gland per se derived from RCC, could be involved in the development of pituitary disorder (9) . RCC is sometimes the cause of hypopituitarism and central diabetes insipidus (10) (11) (12) (13) (14) (15) (16) . RCC is located at various regions in sella turcica and suprasellar space, but in most of the cases the endocrine disturbance occurs at the pituitary level.
In the present study we report a rare case of hypopituitarism and central diabetes insipidus associated with RCC. In particular, the endocrine dysfunction was found to come from the space-occupying lesion at the pituitary stalk level and clinically it was revealed to be the hypothalamic type of hypopituitarism.
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Case Report
A 68-year-old woman had the chief complaints of headache, generalized malaise, poor appetite, weight loss and polyuria. She had had generalized malaise, appetite loss and depressive state since 2003. At that time she also noticed scantiness of ciliac hair, axillar hair and pubic hair, and weight loss of 10 Kg. In 2008 she could not easily walk up the steps at a train station because of muscular lethargy. Thereafter her generalized malaise had further worsened. In addition, symptoms of polyuria and polydipsia occurred, and thus she was admitted to a local hospital in April 2009. She was diagnosed as having central diabetes insipidus, and was treated with DDAVP. Her urine volume was reduced, but her chief symptoms had remained unchanged. So she visited another doctor and was diagnosed as having primary hypothyroidism. She took levothyroxine sodium, and thereafter her generalized malaise become worse. As her headache had not improved, she visited the doctor again. In March 2010 she was admitted to Jichi Medical University Saitama Medical Center for further evaluation.
Her physical findings on admission showed height 152 cm; body weight, 48 Kg and body mass index, 20.9. Blood pressure was 147/69 mmHg without postural change, and pulse rate, 71/min with a regular rhythm. No edema was noted in her legs or feet. She had ciliac, axillar and pubic hair loss. There were no abnormal findings in her head, neck, chest or abdomen. Laboratory findings were as follows: white blood cell count 7,320/mm 3 (neutrophils 41%, lymphocyte 51%, monocyte 6%, eosinophils 2%, basophils 0%); red blood cell count, 413×10 4 /mm 3 ; hemoglobin, 12.3 g/dL; hematocrit, 34.8%; and platelets, 33.1×10 4 /mm 3 . Serum sodium (Na) was 139 mmol/L; potassium, 3.8 mmol/L; and chloride, 105 mmol/L. Blood urea nitrogen was 10 mg/ dL; serum creatinine, 0.72 mg/dL; and uric acid, 6.3 mg/dL. Serum CRP was 1.06 mg/dL. Fasting plasma glucose was 78 mg/dL; hemoglobin A1c, 5.1%; total cholesterol, 205 mg/dL; HDL cholesterol, 22 mg/dL; and triglyceride, 187 mg/dL. Table 1 summarizes the basal levels of various hormones. In assessing the CRH-ACTH-adrenal axis, plasma ACTH level was 4.6 pg/mL with serum cortisol of 1.2 μg/dL. Urinary excretion of free cortisol was as low as<7.7 μg/day. The CRH challenge test showed a prompt increase in ACTH. The peak level of plasma ACTH was 163 pg/mL at 30 minutes (Fig. 1a) . However, there was no increase in plasma ACTH in response to insulin-induced hypoglycemia (Fig. 1b) . Regarding gonadotropin, both serum LH and FSH were markedly reduced. The LH-RH challenge test showed a delayed increase in serum LH and FSH (Fig. 1c) . In contrast, the oral administration of clomiphen did not alter serum LH and FSH levels at all (Fig. 1d) . Serum TSH was 2.5 μU/mL, and serum free T4 and free T3 were 0.7 ng/dL and 2.23 pg/mL, respectively. Serum PRL level was as high as 85.6 ng/mL. Serum TSH level was significantly increased in response to exogenous TRH. Serum GH level was 0.054 ng/mL with IGF-1 of 25 ng/mL. The GRH challenge test showed a delayed increase in GH release. But there was no response of GH release to insulin-induced hypoglycemia (Fig. 1b) .
Urine volume increased to more than 4,000 mL per day, and urinary osmolality was 134 mmol/kg. Plasma AVP level was 0.8 pg/mL despite a plasma osmolality of 298 mmol/kg. The 5% hypertonic saline test clearly showed no increase in urinary osmolality and plasma AVP levels in response to the increase in plasma osmolality from 298 to 322 mmol/Kg.
A space-occupying lesion was located at the pituitary stalk. T1-weighted MRI showed iso-intense signal of an oval mass at the pituitary stalk, with swelling of the pituitary stalk and posterior pituitary. High signal of posterior pituitary disappeared. Also, the upper portion of the pituitary stalk became highly intense. The rim of the oval mass was enhanced by gadolinium. T2-weighted MRI showed a high signal of the oval mass at the pituitary stalk (Fig. 2) .
Clinical Course
We performed extensive examinations to determine the pathological states of diabetes insipidus and hypopituitarism. As noted earlier, she had central diabetes insipidus and hypothalamic type of hypopituitarism, including impaired secretion of CRH, LH-RH, and GRH. Radiological examinations strongly indicated that the endocrine disorders were derived from RCC. However, we could not completely exclude the possibility of cystic neoplasmas or non-neoplasma. She began replacement therapy with DDAVP 10 μg/day, hydrocortisone 15 mg/day, and levothyroxine 25 μg/day. After initiating intranasal administration of DDAVP, she had sufficient urinary concentration. Her main symptoms of generalized malaise, appetite loss and headache disappeared. She gained 7 Kg body weight during the 6-month observation period.
Three months later MRI study was reexamined. The oval mass became high intense on T1-weighted MRI, and (a) (b)
changed to low intense on T2-weighted MRI. T1-weighted MRI showed that the swelling of the pituitary stalk and posterior pituitary did not only disappear, but also the high intensity of the upper portion of the pituitary stalk disappeared (Fig. 3) . After the improvement of Rathke's cleft cyst on MRI imaging, her panhypopituitarism remained.
Discussion
She had had several symptoms of generalized malaise, appetite loss and weight loss for several years prior to admission. Polyuria and polydipsia were manifested, and she was admitted to our hospital and diagnosed as having central diabetes insipidus. As noted earlier, hormonal examinations also revealed the presence of hypopituitarism except for hyperprolactinemia. The clinical course retrospectively implicates that her anterior pituitary disorder probably proceeded the present episode of polyuria and polydipsia, because of the aforementioned symptoms and weight loss.
The most valuable finding is that endocrinological examinations indicated that her hormonal deficiency was closely related to hypothalamic type of disorders in the present patient. She had central diabetes insipidus and impaired secretion of hypothalamic hormones. Basal levels of all the anterior pituitary hormones, except for prolactin and TSH, were reduced, but they were elevated after the stimulation of exogenous hypothalamic hormones. The responses of ACTH and TSH to a single injection of CRH and TRH were enhanced in the present patient. Because basal levels of ACTH and TSH were suppressed under the long-term existence of anterior hypopituitarism, their responses to a single administration of their related hypothalamic hormones could be expected to be impaired. Here we will not go into the explanation of this phenomenon. In contrast, the ACTH and GH releases in response to insulin-induced hypoglycemia were totally blunted. There was no response of gonadotropin to the clomiphene challenge. In addition, the serum prolactin level was elevated. Therefore the endocrinological disorders were based on the hypothalamic type of hypopituitarism. We also found the possibility of GH deficiency. Basal levels of GH and IGF-1 were decreased, and the delayed response of GH to exogenous GRH was proven. In the present patient we could consider to treat for GH deficiency during the clinical course in the outpatient clinic.
MRI showed a cystic lesion in suprasellar space without any abnormality in hypothalumus. As noted ealier the most probable diagnosis of the cystic lesion was RCC. RCC is the remnant of Rathke's pouch from embryonic period. Such a localized purely suprasellar RCC is very rare, and RCC could directly compress the pituitary stalk. Takahashi et al (9) reported that compression of the posterior pituitary by RCC may induce central diabetes insipidus, but compression by other tumors does not. The endocrinological abnormality could be averted at least several years previously based on the history of symptoms and signs. In addition, successive MRI studies clarified that swelling of the pituitary stalk and posterior pituitary disappeared during the 3-month observation period. These findings indicated that enlargement of RCC due to inflammatory change could block the pituitary portal veins and induce axonal degeneration of hypothalamo-neurohypophysial system at the pituitary stalk. Such abnormalities caused endocrinological "hypothalamic dysfunction", resulting in hypopituitarism and central diabetes insipidus. The abnormality remained after the improvement of Rathke's cleft cyst on MR imaging. Surgical removal of the content of RCC might improve the endocrinological dysfunction. However the RCC with inflammatory change was located at the pituitary stalk, and the disturbance had at least persisted since 2003. Thus, we did not choose the surgical treatment in the present patient.
In the literature RCC is a well-known cause of either hypopituitarism or central diabetes insipidus. There are many variations of occupation of RCC in sella turcica. In most of the cases RCC is located in the intrasellar space and, in part, expands to the suprasellar space and results in a spaceoccupying lesion in the sella turcica. We summarized the characteristics of MR imaging in varying pituitary disorders (Table 3) . However, the disturbance of pituitary function is not simply associated with a space occupation of RCC. Rather, inflammation derived from RCC could affect the progression of pituitary dysfunction. It is not common that Rathke's cyst purely resides in the supracellar space (17) . The present case is quite rare in that a space-occupying lesion of RCC compressed the pituitary stalk rather than intrasellar occupation, and it produced an atypical endocrinological disorder of hypothalamic type of hypopituitarism. Swelling of the pituitary stalk and posterior pituitary gland was found with RCC in the present patient. This might be secondarily affected by inflammatory change. As RCC had been present after birth, an additional factor such as inflammation could modify the pathological involvement of RCC in producing endocrinopathy. Because of the occurrence of symptoms and signs, the initiation of anterior hypopituitarism started prior to that of central diabetes insipidus. Thus, we wonder whether the obstruction of the pituitary portal circulation occurred earlier as compared to the degeneration of the hypothalamo-neurohypopyhseal neuron.
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